China Shenghuo Pharmaceutical Holdings, Inc. (NYSE:KUN)
Industry: Healthcare

Listed 11 Consecutive Market Days. On List as of 10/01/2007 Through 10/16/2007

China Shenghuo Pharmaceutical Holdings, Inc. engages in the research, development, manufacture, and marketing of pharmaceutical, nutritional supplement, and cosmetic products in China. Its products are derived from the medicinal herb Panax notoginseng for cardiovascular and cerebrovascular disease, peptic ulcer disease, and health products markets. The company offers Xuesaitong soft capsules to treat cardiovascular and cerebrovascular diseases; Qiye Shenan tablets for headache, insomnia, palpitation, circulation of blood, and liver functionality; Banlangen tablets for treating parotitis, pharyngitis, mastitis, and swollen and sore throat due to cold and influenza; Bergenini tablets to relieve cough and phlegm; and Huangtengsu tablets to treat the symptoms of dysentery, enteritis, respiratory tract infections, uncomplicated urethral, surgery infections, and conjunctivitis. It also provides Danshen tablets to regulate blood circulation and treat the symptoms of blood stasis, coronary arteriosclerosis, angina pectoris, and hyperlipemia; Triperygium hypoglaucum Hutch tablets for treating symptoms of rheumatoid arthritis; Huangtengsu Soft Capsules to treat symptoms of dysentery, enteritis, respiratory tract infections, surgery infections, and conjunctivitis; Tian Xin Soft capsules to reduce blood viscosity and enhance blood circulation; and Radix Polygoni Multiflori capsules to treat effects of weakness of the kidney and liver, fatigue, and dizziness due to blood deficiencies. The companys Phase II clinical trial products include Wei Dingkang soft capsules, and Dencichine Hemostat. In addition, it offers over-the-counter supplements, and vitamin capsules and pills, as well as cosmetic products, including lotions, creams, and other cosmetic items. The company sells its pharmaceutical products under the Lixuwang and Shenghuo names to regional wholesale companies and retail drug stores. China Shenghuo Pharmaceutical Holdings is based in Kunming, China.

Current Quote*
Last: $0.140
Change: 0.000
Book: $7.600
Volume: Unk

As Of: 08/30 13:17 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol KUN

  • No BuyIns.Net Alerts Available for KUN

Graphs for KUN


3 Month Graph


6 Month Graph


1 Year Graph